Is the FCPA Dead? What the Enforcement Pause Means for Companies
Join us on Thursday 6 March 2025 from 10 – 11 AM SGT, to discuss the considerations that medical device, MedTech and diagnostic companies should take into account, in deciding whether (and how) to right-size compliance programs and functions in Asia Pacific in light of the current FCPA enforcement climate. This session is targeted at legal/compliance personnel, as well as business leaders, and will take into account the specific challenges faced by this industry.
Exclusively for APACMed Members. For enquiries, please contact info@apacmed.org.
